Importantly, PDGFRA, known as the core regulator of angiogenesis, was the only TG that showed a negative correlation with OS at both the mRNA and protein levels, suggesting that HMGB1 might drive patients’ poor prognosis by promoting tumor angiogenesis (Fig. 5g). Here, HMGB1 is linked to neoplasm.